Cowen Starts Unum Therapeutics (UMRX) at Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St set for higher open but weekly losses loom
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Wedbush Starts Unum Therapeutics (UMRX) at Outperform
April 23, 2018 6:43 AM EDTWedbush initiates coverage on Unum Therapeutics (NASDAQ: UMRX) with a Outperform rating and a price target of $18.00.
Analyst David Nierengarten comments "UMRX shares are undervalued given the universal approach of their proprietary Antibody-Coupled T-Cell Receptor (ACTR) platform, an engineered cell construct with... More
SunTrust Robinson Humphrey Starts Unum Therapeutics (UMRX) at Buy
April 23, 2018 6:22 AM EDTSunTrust Robinson Humphrey initiates coverage on Unum Therapeutics (NASDAQ: UMRX) with a Buy rating and a price target of $21.00.
For an analyst ratings summary and ratings history on Unum Therapeutics click here. For more ratings news on Unum Therapeutics click here.
Shares of Unum Therapeutics closed at $11.98 Friday.
... MoreMorgan Stanley Starts Unum Therapeutics (UMRX) at Overweight
April 23, 2018 5:35 AM EDTMorgan Stanley initiates coverage on Unum Therapeutics (NASDAQ: UMRX) with a Overweight rating and a price target of $20.00.
For an analyst ratings summary and ratings history on Unum Therapeutics click here. For more ratings news on Unum Therapeutics click here.
Shares of Unum Therapeutics closed at $11.98 Friday.
... More